IMA Stock Analysis: Buy, Sell, or Hold?
IMA - ImageneBio, Inc. Common Stock
$5.00
0.00 (0.00%)
▲
5d:
-11.19%
30d:
-25.6%
90d:
-13.79%
WAIT
LOW Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 14, 2026
Get Alerted When IMA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: IMA is down 11.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: IMA is down 11.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: IMA is currently trading at $5.00, which is considered oversold relative to its 30-day fair value range of $5.52 to $6.55.
Technical Outlook: Technically, IMA is in a downtrend. Immediate support is located at $3.94, while resistance sits at $6.50.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $30.00 (+500.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IMA is in a downtrend. Immediate support is located at $3.94, while resistance sits at $6.50.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $30.00 (+500.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$5.52 -
$6.55
Company Quality Score
36/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 500.0% below Wall St target ($30.00)
- WARNING: Recommendation downgraded due to -11.2% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$5.52 -
$6.55
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$3.94
Resistance Level
$6.51
Current Trend
Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.51
Wall Street Target
$30.00
(+500.0%)
Share & Embed Analysis
Last updated: March 30, 2026 4:29 PM ET
Data refreshes hourly during market hours. Next update: 5:29 PM
Data refreshes hourly during market hours. Next update: 5:29 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMA showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Joseph P Slattery
BUY
16000 shares
2025-12-24
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$89 | 54 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 51 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 50 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$547 | 44 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$119 | 54 HOLD |